Research summary ·
Effects of Benzodiazepines on Heart Failure Outcomes and Adverse Events: A Systematic Review and Meta-Analysis.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review looked at benzodiazepines for insomnia and heart failure. The team searched several databases up to August 7, 2025. They pulled hazard ratios and risk ratios for heart failure outcomes. They pooled results with a random-effects model. They rated study quality with the Newcastle-Ottawa Scale. Follow-up in the studies ranged from 180 days to 15 years.
What they found
Benzodiazepine use was linked to a higher risk of new heart failure. The hazard ratio was 1.41. It was also linked to more hospital stays for heart failure. The hazard ratio there was 1.29. Compared with antipsychotics, z-drugs and suvorexant, benzodiazepines also suggested more hospital stays and repeat stays.
What it means for patients
The team says benzodiazepine use was linked to a higher risk of heart failure outcomes. They say the findings show links, not cause. They say caution is needed with these drugs in people at risk of heart failure.
Why it is not certain yet
Most included studies were observational. The findings show links and not cause. The abstract says the effects were unclear, especially in high-risk groups. A review can only be as good as the studies in it.
Source
Effects of Benzodiazepines on Heart Failure Outcomes and Adverse Events: A Systematic Review and Meta-Analysis.
PubMed · PMID 42832119We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Insomnia publications